Allele-specific silencing of the gain-of-function mutation in Huntington’s disease using CRISPR/Cas9 is a research paper published in JCI Insight (2022). On theSindex it has a DataRank of 0.533. It has been cited 34 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.533
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NINDS
Grant: NS105709
NINDS
Grant: NS119471
National Institute of Health
Grant: R00 CA218870
NINDS
Grant: NS105709,NS119471,R00 CA218870
NINDS NIH HHS
Grant: R01 NS105709
NINDS NIH HHS
Grant: R01 NS119471
National Institutes of Health
Grant: 5R01NS119471-02
Therapeutic potential of base editing strategies to convert CAG to CAA in Huntington's Disease
National Institutes of Health
Grant: 5R00CA218870-04
Optimizing Cancer Immunotherapy Safety and Efficacy using Genome Editing
National Institutes of Health
Grant: 5R01NS105709-02
Genetic foundation for complete mutant allele-specific CRISPR in neurodegenerative diseases
FWCI
2.59
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords